IRD as of Oct 31 · 19:24 ET
IRDNasdaqPharmaceutical Preparations

Opus Genetics, Inc. · Brief

Next report

11 days

Nov 11 · before openest.Q3 FY26

Expected move

No implied move.

Implied vs realized

1 reportHistory
—≥ implied
Q2 FY26±41.2%▼−1.59%×0.04
quarterimplied−45%0+45%realized×
Q2 FY26±41.2%▼−1.59%×0.04
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 11 report · est.

Bull2

4disclosed supplier and customer ties in SEC filingsSEC filings
103managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear1

3 of 24of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Oct 26 '26once per report · top 2 per case

Linked exposure

IRD report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 28impliedImplied move: ±35.8% into Nov 11 earnings (Oct 28 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.